Spero Therapeutics Inc (NAS:SPRO)
$ 1.4399 -0.0101 (-0.7%) Market Cap: 77.73 Mil Enterprise Value: 1.25 Mil PE Ratio: 3.27 PB Ratio: 0.80 GF Score: 40/100

Q3 2021 Spero Therapeutics Inc Earnings Call Transcript

Nov 10, 2021 / 09:30PM GMT
Release Date Price: $17.02 (-1.39%)
Operator

Good afternoon, and welcome to the Spero Therapeutics Third Quarter 2021 Financial Results Conference Call. (Operator Instructions) Please be advised that this call is being recorded and a replay will be available. You can find information on the replay and further information related to today's announcement on the Spero Therapeutics website at www.sperotherapeutics.com.

At this time, I'd like to turn the call over to Ted Jenkins, Vice President, Head of Investor Relations at Spero Therapeutics. Mr. Jenkins, please go ahead.

Ted Jenkins
Spero Therapeutics, Inc. - VP & Head of IR

Thank you, operator, and thank you all for participating in today's conference call. This afternoon, Spero Therapeutics released financial results and provided a pipeline update for the third quarter of 2021. Our press release is available on the Investors page of the Spero Therapeutics website.

Before we begin, I'd like to remind you that some of the information contained in the news

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot